Earlier Anti-Tumor Necrosis Factor Therapy of Crohn’s Disease Correlates with Slower Progression of Bowel Damage

Therapy aimed at neutralizing the effects of tumor necrosis factor (TNF) have revolutionized the therapy of IBD. In a retrospective study, the authors determined that early initiation of anti-TNF therapy slowed the progression of Crohn's disease. https://